NeurosurgeonLenox Hill Hospital, United States
Preliminary Results of the FRONTIER Trial: Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma
Wednesday, April 2, 20258:21 AM – 8:28 AM CT